Skip to content

Conservative versus surgical treatment of grade III acromioclavicular dislocations

Conservative versus surgical treatment of grade III acromioclavicular dislocations: prospective and randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4r6jhy6
Enrollment
Unknown
Registered
2022-12-13
Start date
2023-01-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dislocation of the acromioclavicular joint

Interventions

Acromioclavicular dislocation is one of the most common traumatic shoulder injuries and typically occurs in young individuals who participate in contact sports. It is the most common shoulder injury i
E02.779

Sponsors

Centro de Traumatologia do Esporte da Escola Paulista de Medicina
Lead Sponsor
Centro de Traumatologia do Esporte da Escola Paulista de Medicina
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Both genders; over 18 years of age; type III acromioclavicular dislocations with up to 21 days of evolution; absence of acromioclavicular dislocation in the shoulder in question; absence of previous surgery on the shoulder in question; absence of concomitant fracture of the acromion, coracoid or clavicle; signing the consent form.

Exclusion criteria

Exclusion criteria: Patients who did not meet the return schedule; patients in whom radiological examinations were not performed correctly; patients who did not comply with the proposed rehabilitation program.

Design outcomes

Primary

MeasureTime frame
The primary assessment tool will be the DASH, which consists of a 30-item scale ranging from 0 (no dysfunction) to 100. Patients undergoing surgical treatment are expected to present superior results. Patients will be evaluated at 3 weeks, 6 weeks, 3 months, 6 months and 1 year. The evaluations will be carried out by a member of the study and will be carried out with a shoulder covered with adhesive tape to allow the evaluator to be blinded in relation to the treatment performed.

Secondary

MeasureTime frame
Radiographic assessment. Patients undergoing surgical treatment are expected to present less arthritis at the acromioclavicular joint. Patients will be evaluated at 3 weeks, 6 weeks, 3 months, 6 months and 1 year. The evaluations will be carried out by a member of the study and will be carried out with a shoulder covered with adhesive tape to allow the evaluator to be blinded in relation to the treatment performed.;Range of motion assessment. Patients undergoing surgical treatment are expected to present superior results. Patients will be evaluated at 3 weeks, 6 weeks, 3 months, 6 months and 1 year. The evaluations will be carried out by a member of the study and will be carried out with a shoulder covered with adhesive tape to allow the evaluator to be blinded in relation to the treatment performed.;Cosmetic outcome. Patients undergoing surgical treatment are expected to present superior results. Patients will be evaluated at 3 weeks, 6 weeks, 3 months, 6 months and 1 year. The evaluations will be carried out by a member of the study and will be carried out with a shoulder covered with adhesive tape to allow the evaluator to be blinded in relation to the treatment performed.;Scapular dyskinesia, which will be graded according to Kibler's classification. Patients undergoing surgical treatment are expected to present superior results. Patients will be evaluated at 3 weeks, 6 weeks, 3 months, 6 months and 1 year. The evaluations will be carried out by a member of the study and will be carried out with a shoulder covered with adhesive tape to allow the evaluator to be blinded in relation to the treatment performed.

Countries

Brazil

Contacts

Public ContactPaulo Lara

Centro de Traumatologia do Esporte da Escola Paulista de Medicina

phslara@gmail.com5511 3003-2442

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 2, 2026